Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
出版年份 2021 全文链接
标题
Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-09-29
DOI
10.3389/fimmu.2021.733530
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?
- (2021) Alessandro Rizzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Atezolizumab in advanced hepatocellular carcinoma: good things come to those who wait
- (2021) Alessandro Rizzo et al. Immunotherapy
- Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
- (2021) Robin Kate Kelley et al. JOURNAL OF CLINICAL ONCOLOGY
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
- (2020) Won Jin Ho et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis
- (2020) Marisol Miranda Galvis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design
- (2020) Robin Kate Kelley et al. Future Oncology
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
- (2020) Michael S Lee et al. LANCET ONCOLOGY
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
- (2020) John D. Gordan et al. JOURNAL OF CLINICAL ONCOLOGY
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review
- (2019) Barbora Peltanova et al. Molecular Cancer
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma
- (2019) Lynn G. Feun et al. CANCER
- Harnessing tumor-associated macrophages as aids for cancer immunotherapy
- (2019) Xiaolei Li et al. Molecular Cancer
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Hepatitis B virus infection
- (2018) Man-Fung Yuen et al. Nature Reviews Disease Primers
- Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy
- (2017) Maryam Tahmasebi Birgani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- A principal component analysis is conducted for a case series quality appraisal checklist
- (2016) Bing Guo et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Drug delivery to macrophages: Challenges and opportunities
- (2016) Yihua Pei et al. JOURNAL OF CONTROLLED RELEASE
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Toward a more accurate estimate of the prevalence of hepatitis C in the United States
- (2015) Brian R. Edlin et al. HEPATOLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma
- (2014) Ashraf Ali WORLD JOURNAL OF GASTROENTEROLOGY
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples
- (2012) Günter P. Wagner et al. THEORY IN BIOSCIENCES
- Expansion of CD4+CD25+FoxP3+regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma
- (2010) Kai Yoshizawa et al. HEPATOLOGY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now